Showing results (71-80 of 118) with videos related to
Sort By:
Pageof 12
Oncotarget|April 8, 2017
Genetic landscape of extreme responders with anaplastic oligodendrogliomaMatthias Holdhoff, Gregory J Cairncross, Thomas M Kollmeyer, et al.Neuro-Oncology|April 4, 2017
Timed sequential therapy of the selective T-type calcium channel blocker mibefradil and temozolomide in patients with recurrent high-grade gliomasMatthias Holdhoff, Xiaobu Ye, Jeffrey G Supko, et al.World Neurosurgery|February 13, 2025
Trends in the Management of Oligodendrogliomas: A Multinational and Multidisciplinary Survey StudyKelly Jiang, Anita Kalluri, Michelle Odonkor, et al.Neuro-Oncology Advances|October 7, 2024
Lisavanbulin (BAL101553), a novel microtubule inhibitor, plus radiation in patients with newly diagnosed, MGMT promoter unmethylated glioblastomaMatthias Holdhoff, Xiaobu Ye, Roy E Strowd, et al.Journal of Cardiovascular Computed Tomography|April 7, 2019
Validation of the Coronary Artery Calcium Data and Reporting System (CAC-DRS): Dual importance of CAC score and CAC distribution from the Coronary Artery Calcium (CAC) consortiumOmar Dzaye, Ramzi Dudum, Mohammadhassan Mirbolouk, et al.Journal of Oncology Practice|August 7, 2019
Immune-Related Adverse Events Requiring Hospitalization: Spectrum of Toxicity, Treatment, and OutcomesAanika Balaji, Jiajia Zhang, Beatriz Wills, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 16, 2017
Reduced-Intensity Haploidentical Bone Marrow Transplantation with Post-Transplant Cyclophosphamide for Solid Tumors in Pediatric and Young Adult PatientsNicolas J Llosa, Kenneth R Cooke, Allen R Chen, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 27, 2014
First-in-human dose study of the novel transforming growth factor-β receptor I kinase inhibitor LY2157299 monohydrate in patients with advanced cancer and gliomaJordi Rodon, Michael A Carducci, Juan M Sepulveda-Sánchez, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 1, 2016
Repeatability of 18F-FLT PET in a Multicenter Study of Patients with High-Grade GliomaMartin A Lodge, Matthias Holdhoff, Jeffrey P Leal, et al.Neurosurgery|June 25, 2025
Risk Factors, Indications, and Effectiveness of Cerebrospinal Fluid Diversion in Patients With High-Grade Glioma-Associated Hydrocephalus: A Systematic Review and Meta-AnalysisJovanna A Tracz, Max A Saint-Germain, Cathleen C Kuo, et al.Pageof 12